Dandan Wan
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 5
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Xiawei Wei (8 shared papers)Yuquan Wei (4 shared papers)Manni Wang (2 shared papers)Minyang Fu (2 shared papers)Jian Liu (1 shared paper)Weiqi Hong (7 shared papers)Qin He (6 shared papers)Man Li (6 shared papers)
- Journals
- Acta Biomaterialia (3 papers)Journal of Controlled Release (3 papers)Signal Transduction and Targeted Therapy (2 papers)Nature Communications (1 paper)Journal of Hematology & Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Dandan Wan
17 papers receiving 1.1k citations
Dandan Wan's Hit Papers
Peers
Comparison fields: 5 of 69
- Immunology 401
- Biomaterials 222
- Oncology 206
- Drug Discovery 2
- Pharmaceutical Science 45
Countries citing papers authored by Dandan Wan
This map shows the geographic impact of Dandan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Wan more than expected).
Fields of papers citing papers by Dandan Wan
This network shows the impact of papers produced by Dandan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Wan. The network helps show where Dandan Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Dandan Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer vaccines as promising immuno-therapeutics: platforms and current progress Hit paper breakdown → | 2022 | 572 |
| 2 | 2021 | 104 | |
| 3 | 2021 | 74 | |
| 4 | 2018 | 72 | |
| 5 | 2018 | 55 | |
| 6 | 2022 | 55 | |
| 7 | 2019 | 43 | |
| 8 | 2021 | 42 | |
| 9 | 2019 | 37 | |
| 10 | 2024 | 34 | |
| 11 | 2022 | 23 | |
| 12 | 2020 | 15 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2025 | 5 | |
| 16 | 2023 | 2 | |
| 17 | 2026 | 1 | |
| 18 | 2026 | 0 |
About Dandan Wan
Dandan Wan is a scholar working on Biomaterials, Immunology, Infectious Diseases, Pharmaceutical Science and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Immunotherapy and Immune Responses (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Nanoplatforms for cancer theranostics (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), RNA Interference and Gene Delivery (1 paper), COVID-19 Clinical Research Studies (1 paper) and Advanced Drug Delivery Systems (1 paper). The work is most often cited by research in Immunology (401 citations), Biomaterials (222 citations), Oncology (206 citations), Drug Discovery (2 citations) and Pharmaceutical Science (45 citations). Dandan Wan has collaborated with scholars based in China. Frequent co-authors include Xiawei Wei, Yuquan Wei, Manni Wang, Minyang Fu, Jian Liu, Weiqi Hong, Qin He, Man Li, Haiying Que and Zhirong Zhang. Their work appears in journals such as Acta Biomaterialia, Journal of Controlled Release, Signal Transduction and Targeted Therapy, Nature Communications and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.